Skip to main content
If you think legalizing marijuana won't affect you... Think Again.
Main menu
Home
Articles, Studies, Research
Rx Marijuana
Epilepsy
Colorado
Other Resources
You are here
Home
Two 24-Week Phase 3 Studies of Lumacaftor in Combination with Ivacaftor Met Primary Endpoint with Statistically Significant Improvements in Lung Function
Link:
Two 24-Week Phase 3 Studies of Lumacaftor in Combination with Ivacaftor Met Primary Endpoint with Statistically Significant Impr
Article Date:
Tuesday, June 24, 2014
Tags:
Cystic Fibrosis
FDA
Research
Click here to Print the Page
Click here to Print the Page
